1 active not recruiting, 1 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Completed 1 |
Follow RestoreX: new trials by email Literature Review of RestoreX trials Research Report on RestoreX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease Collagenase Clostridium Histolyticum, RestoreX, Sildenafil - Peyronie Disease | Phase 4 | Active not recruiting | Charitable Union for the Research and Education of Peyronie's Disease | 40 | 2024-10-11 | 2026-08-26 |
| Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders CCH administration, Control - Crossover to CCH, RestoreX - Peyronie's Disease | Phase 4 | Completed | Charitable Union for the Research and Education of Peyronie's Disease | 40 | 2021-09-20 | 2026-08-26 |
Charitable Union for the Research and Education of Peyronie's Disease (2)
United States (2)
Landon Trost, MD (2)